Cargando…
The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse
AIMS/HYPOTHESIS: The aim of this study was to determine whether therapy with the cytokine IL-22 could be used to prevent the development of, or treat, autoimmune diabetes in the NOD mouse. METHODS: Six-week-old NOD mice were administered bi-weekly either recombinant mouse IL-22 (200 ng/g) or PBS (ve...
Autores principales: | Borg, Danielle J., Wang, Ran, Murray, Lydia, Tong, Hui, Steptoe, Raymond J., McGuckin, Michael A., Hasnain, Sumaira Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448904/ https://www.ncbi.nlm.nih.gov/pubmed/28779211 http://dx.doi.org/10.1007/s00125-017-4392-2 |
Ejemplares similares
-
Interleukin (IL)-22 from IL-20 Subfamily of Cytokines Induces Colonic Epithelial Cell Proliferation Predominantly through ERK1/2 Pathway
por: Moniruzzaman, Md., et al.
Publicado: (2019) -
Fibre Intake Is Independently Associated with Increased Circulating Interleukin-22 in Individuals with Metabolic Syndrome
por: Torquati, Luciana, et al.
Publicado: (2019) -
Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized Trial
por: Ramos, Joyce S, et al.
Publicado: (2020) -
Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells
por: Moniruzzaman, Md, et al.
Publicado: (2023) -
Serine Protease(s) Secreted by the Nematode Trichuris muris Degrade the Mucus Barrier
por: Hasnain, Sumaira Z., et al.
Publicado: (2012)